Local overexpression of interleukin-11 in the central nervous system limits demyelination and enhances remyelination

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Maheshwari, Anurag ^a   Janssens, Kris ^a   Bogie, Jeroen ^a   Van Den Haute, Chris ^b   Struys, Tom ^a   Lambrichts, Ivo ^a   Baekelandt, Veerle ^b   Stinissen, Piet ^a   Hendriks, Jerome J A ^a   Slaets, Helena ^a   Hellings, Niels ^a  

^a HASSELT UNIVERSITY   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CCL1 CHEMOKINE; CUPRIZONE; INTERLEUKIN 11; LENTIVIRUS VECTOR; MYELIN; RECOMBINANT INTERLEUKIN 11;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN; CELL MATURATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMYELINATION; DRUG EFFICACY; ELECTRON MICROSCOPY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LENTIVIRINAE; LUXOL FAST BLUE STAINING; MALE; MEDIATOR; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROCYTE PROGENITOR CELL; OLIGODENDROGLIA; PHAGOCYTOSIS; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REMYELINIZATION; STAINING; STEM CELL; SYMPTOM; VIRAL GENE DELIVERY SYSTEM; ANIMAL; C57BL MOUSE; CELL PROLIFERATION; CYTOLOGY; DEMYELINATING DISEASES; DRUG EFFECTS; GENETICS; METABOLISM; MICROGLIA; MYELIN SHEATH; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; DEMYELINATING DISEASE; DRUG EFFECT;

ANIMALIA;

ANIMALS; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CUPRIZONE; DEMYELINATING DISEASES; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-11; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; MICROSCOPY, ELECTRON, TRANSMISSION; MYELIN SHEATH;

EID: 84879293263     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/685317     Document Type: Article

References (41)

1. Venken K., Hellings N., Liblau R., Stinissen P., Disturbed regulatory T cell homeostasis in multiple sclerosis. Trends in Molecular Medicine 2010 16 2 58 68 2-s2.0-76249094369 10.1016/j.molmed.2009.12.003
2. McFarlin D. E., McFarland H. F., Multiple sclerosis (first of two parts). The New England Journal of Medicine 1982 307 19 1183 1188 2-s2.0-0019980359
3. McFarlin D. E., McFarland H. F., Multiple sclerosis.(second of two parts). The New England Journal of Medicine 1982 307 20 1246 1251 2-s2.0-0020287147
4. McFarland H. F., Martin R., Multiple sclerosis: a complicated picture of autoimmunity. Nature Immunology 2007 8 9 913 919 2-s2.0-34548133584 10.1038/ni1507
5. Lassmann H., Mechanisms of demyelination and tissue destruction in multiple sclerosis. Clinical Neurology and Neurosurgery 2002 104 3 168 171 2-s2.0-0036074810 10.1016/S0303-8467(02)00033-1
6. Lassmann H., van Horssen J., The molecular basis of neurodegeneration in multiple sclerosis. FEBS Letters 2011 585 23 3715 3723 10.1016/j.febslet.2011. 08.004
7. Prineas J. W., Kwon E. E., Goldenberg P. Z., Ilyas A. A., Quarles R. H., Benjamins J. A., Sprinkle T. J., Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions. Laboratory Investigation 1989 61 5 489 503 2-s2.0-0024368562
8. Raine C. S., Wu E., Multiple sclerosis: remyelination in acute lesions. Journal of Neuropathology and Experimental Neurology 1993 52 3 199 204 2-s2.0-0027173943
9. Kieseier B. C., Hemmer B., Hartung H. P., Multiple sclerosis-novel insights and new therapeutic strategies. Current Opinion in Neurology 2005 18 3 211 220 2-s2.0-20444457446
10. Wolswijk G., Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. The Journal of Neuroscience 1998 18 2 601 609 2-s2.0-0031962240
11. Kotter M. R., Stadelmann C., Hartung H. P., Enhancing remyelination in disease-can we wrap it up? Brain 2011 134 7 1882 1900 2-s2.0-79959744924 10.1093/brain/awr014
12. Trepicchio W. L., Dorner A. J., Interleukin-11: a gp130 cytokine. Annals of the New York Academy of Sciences 1998 856 12 21 2-s2.0-0031768528
13. Zhang Y., Taveggia C., Melendez-Vasquez C., Einheber S., Raine C. S., Salzer J. L., Brosnan C. F., John G. R., Interleukin-11 potentiates oligodendrocyte survival and maturation, and myelin formation. The Journal of Neuroscience 2006 26 47 12174 12185 2-s2.0-33751316986 10.1523/JNEUROSCI.2289- 06.2006
14. Slaets H., Hendriks J. J. A., Van Den Haute C., Coun F., Baekelandt V., Stinissen P., Hellings N., CNS-targeted lif expression improves therapeutic efficacy and limits autoimmune-mediated demyelination in a model of multiple sclerosis. Molecular Therapy 2010 18 4 684 691 2-s2.0-77950516252 10.1038/mt.2009.311
15. + T cells. Journal of Interferon and Cytokine Research 2001 21 1 21 30 2-s2.0-0035137141 10.1089/107999001459123
16. + T cells. Blood 2001 97 9 2758 2763 2-s2.0-0035353159 10.1182/blood.V97.9.2758
17. Trepicchio W. L., Wang L., Bozza M., Dorner A. J., IL-11 regulates macrophage effector function through the inhibition of nuclear factor- B. Journal of Immunology 1997 159 11 5661 5670 2-s2.0-0031298532
18. Zhang J., Zhang Y., Dutta D. J., Argaw A. T., Bonnamain V., Seto J., Braun D. A., Zameer A., Hayot F., Lòpez C. B., Raine C. S., John G. R., Proapoptotic and antiapoptotic actions of stat1 versus stat3 underlie neuroprotective and immunoregulatory functions of il-11. Journal of Immunology 2011 187 3 1129 1141 10.4049/jimmunol.1004066
19. Gurfein B. T., Zhang Y., López C. B., Argaw A. T., Zameer A., Moran T. M., John G. R., IL-11 regulates autoimmune demyelination. Journal of Immunology 2009 183 7 4229 4240 2-s2.0-70449725291 10.4049/jimmunol.0900622
20. Mason J. L., Langaman C., Morell P., Suzuki K., Matsushima G. K., Episodic demyelination and subsequent remyelination within the murine central nervous system: changes in axonal calibre. Neuropathology and Applied Neurobiology 2001 27 1 50 58 2-s2.0-0035074894 10.1046/j.0305-1846.2001.00301.x
21. Matsushima G. K., Morell P., The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathology 2001 11 1 107 116 2-s2.0-0035198691
22. Baekelandt V., Claeys A., Eggermont K., Lauwers E., De Strooper B., Nuttin B., Debyser Z., Characterization of lentiviral vector-mediated gene transfer in adult mouse brain. Human Gene Therapy 2002 13 7 841 853 2-s2.0-0036247444 10.1089/10430340252899019
23. Geraerts M., Eggermont K., Hernandez-Acosta P., Garcia-Verdugo J. M., Baekelandt V., Debyser Z., Lentiviral vectors mediate efficient and stable gene transfer in adult neural stem cells in vivo. Human Gene Therapy 2006 17 6 635 650 2-s2.0-33745670134 10.1089/hum.2006.17.635
24. Paxinos G., Franklin K. B. J., The Mouse Brain in Stereotaxic Coordinates 2001 2nd San Diego, Calif, USA Academic Press
25. Struys T., Ketkar-Atre A., Gervois P., Leten C., Hilkens P., Martens W., Bronckaers A., Dresselaers T., Politis C., Lambrichts I., Himmelreich U., Magnetic resonance imaging of human dental pulp stem cells in vitro and in vivo. Cell Transplantation 2012 10.3727/096368912X657774
26. Stidworthy M. F., Genoud S., Suter U., Mantei N., Franklin R. J. M., Quantifying the early stages of remyelination following cuprizone-induced demyelination. Brain Pathology 2003 13 3 329 339 2-s2.0-0041625961
27. Hendriks J. J. A., Slaets H., Carmans S., de Vries H. E., Dijkstra C. D., Stinissen P., Hellings N., Leukemia inhibitory factor modulates production of inflammatory mediators and myelin phagocytosis by macrophages. Journal of Neuroimmunology 2008 204 1-2 52 57 2-s2.0-54849427453 10.1016/j.jneuroim.2008. 07.015
28. Acs P., Komoly S., Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination. Ideggyogyaszati Szemle 2012 65 7-8 266 270
29. Kipp M., Clarner T., Dang J., Copray S., Beyer C., The cuprizone animal model: new insights into an old story. Acta Neuropathologica 2009 118 6 723 736 2-s2.0-71449117143 10.1007/s00401-009-0591-3
30. Torkildsen O., Brunborg L. A., Myhr K. M., Bø L., The cuprizone model for demyelination. Acta Neurologica Scandinavica 2008 117 188 72 76 2-s2.0-42949163922 10.1111/j.1600-0404.2008.01036.x
31. Mason J. L., Jones J. J., Taniike M., Morell P., Suzuki K., Matsushima G. K., Mature oligodendrocyte apoptosis precedes igf-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination. Journal of Neuroscience Research 2000 61 3 251 262
32. Chomiak T., Hu B., What is the optimal value of the g-ratio for myelinated fibers in the rat CNS? A theoretical approach. PLoS One 2009 4 11 2-s2.0-70649084126 10.1371/journal.pone.0007754 e7754
33. Kerschensteiner M., Meinl E., Hohlfeld R., Neuro-immune crosstalk in CNS diseases. Neuroscience 2009 158 3 1122 1132 2-s2.0-59349095043 10.1016/j.neuroscience.2008.09.009
34. Vanderlocht J., Hellings N., Hendriks J. J. A., Vandenabeele F., Moreels M., Buntinx M., Hoekstra D., Antel J. P., Stinissen P., Leukemia inhibitory factor is produced by myelin-reactive T cells from multiple sclerosis patients and protects against tumor necrosis factorinduced oligodendrocyte apoptosis. Journal of Neuroscience Research 2006 83 5 763 774 2-s2.0-33645321113 10.1002/jnr.20781
35. Bénardais K., Kotsiari A., Skuljec J., Koutsoudaki P. N., Gudi V., Singh V., Vulinovic F., Skripuletz T., Stangel M., Cuprizone [bis(cyclohexylidenehydrazide)] is selectively toxic for mature oligodendrocytes. Neurotoxicity Research 2013 10.1007/s12640-013-9380-9
36. Slaets H., Dumont D., Vanderlocht J., Noben J. P., Leprince P., Robben J., Hendriks J., Stinissen P., Hellings N., Leukemia inhibitory factor induces an antiapoptotic response in oligodendrocytes through Akt-phosphorylation and up-regulation of 14-3-3. Proteomics 2008 8 6 1237 1247 2-s2.0-41549154629 10.1002/pmic.200700641
37. Pasquini L. A., Calatayud C. A., Bertone Uña A. L., Millet V., Pasquini J. M., Soto E. F., The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia. Neurochemical Research 2007 32 2 279 292 2-s2.0-33846930155 10.1007/s11064-006-9165-0
38. Zaheer A., Zaheer S., Sahu S. K., Knight S., Khosravi H., Mathur S. N., Lim R., A novel role of glia maturation factor: induction of granulocyte-macrophage colony-stimulating factor and pro-inflammatory cytokines. Journal of Neurochemistry 2007 101 2 364 376 2-s2.0-34047139460 10.1111/j.1471-4159.2006.04385.x
39. Starossom S. C., Mascanfroni I. D., Imitola J., Cao L., Raddassi K., Hernandez S. F., Bassil R., Croci D. O., Cerliani J. P., Delacour D., Wang Y., Elyaman W., Khoury S. J., Rabinovich G. A., Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration. Immunity 2012 37 2 249 263 10.1016/j.immuni.2012.05.023
40. Leng S. X., Elias J. A., Interleukin-11 inhibits macrophage interleukin-12 production. Journal of Immunology 1997 159 5 2161 2168 2-s2.0-0031229726
41. Cho N., Nguyen D. H., Satkunendrarajah K., Branch D. R., Fehlings M. G., Evaluating the role of il-11, a novel cytokine in the il-6 family, in a mouse model of spinal cord injury. Journal of Neuroinflammation 2012 9 134 10.1186/1742-2094-9-134